-
-
Call more information
660-596-2224 -
Author: Robin Hocevar ASA Monitor September 2023, Vol. 87, 30. Pediatric anesthesiologist Philip Yun, DO, participated in a surgery to treat an abdominal aortic aneurysm during his residency, but never in his work as attending physician in the NICU at Oregon Health & Science University (OHSU) Doernbecher Children’s Hospital. Often referred to as “AAA,” an abdominal […]
Read MoreAuthors: Paloma Toledo, MD, MPH; Vesela P. Kovacheva, MD, PhD ASA Monitor September 2023, Vol. 87, 37. Recent reports of increased maternal mortality have put pregnancy care in the center of the public’s attention. The World Health Organization defines maternal death as the death of a woman while pregnant or within 42 days of termination of pregnancy […]
Read MoreASA Monitor September 2023, Vol. 87, 9. A 46-year-old woman presents to the intensive care unit with a diagnosis of acute pancreatitis. According to a recent study that compared aggressive fluid resuscitation with moderate fluid resuscitation, development of which of the following conditions was MOST likely increased with aggressive fluid resuscitation? □ (A) Moderately severe or severe […]
Read MoreASA Monitor September 2023, Vol. 87, 8. A 56-year-old woman is scheduled for an extensive surgical procedure. She weighs 50 kg and her hematocrit prior to surgery is 37%. You determine that an intraoperative hematocrit of 21% would necessitate transfusion of packed red blood cells. What is this patient’s MAXIMUM allowable blood loss? (A) 700 mL […]
Read MoreAuthor: Devin Van Gorden ASA Monitor September 2023, Vol. 87, 27. The number of anesthesiologists applying for fellowships after graduating from residency has grown substantially over the last 20 years. From 2017-2020, the percentage of anesthesiologists completing their residency and entering fellowships more than doubled. Fellowship participants will be primed to take on the most complex, […]
Read MoreASA Monitor September 2023, Vol. 87, 15–32. Gel capsules mimic vegetables and promote weight loss Gelesis is a biotech company utilizing biomimicry to tackle obesity and gastrointestinal-related diseases. Its oral hydrogel technology, Plenity, was approved by the FDA in 2019 after clinical studies showed it helped 60% of users lose weight over the course of six […]
Read MoreAuthors: Hyundeok Joo, MD, MAS et al ASA Monitor September 2023, Vol. 87, 1–7. Durable, functionally impactful, and subjectively evident cognitive decline is a feared outcome of anesthesia and surgery, particularly for older adults (Br J Anaesth 2017;118:486-8). We need to look no further than Dr. Daniel Cole, a coauthor of this article and the editor […]
Read MoreAuthor: Mary Dale Peterson, MD, MHA, FACHE, FASA ASA Monitor September 2023, Vol. 87, 11. As a health care executive (HCE), I know first-hand the challenges nearly every hospital and health system faces in today’s constrained environment. While some of the issues may vary regionally, many institutions are having to do more with less due to […]
Read MoreAuthors: Dibash Kumar Das, PhD; Steven Shafer, MD, FASA ASA Monitor September 2023, Vol. 87, 1–4. Hosting the 95th Academy Awards, Jimmy Kimmel opened his monologue by saying, “Everybody looks so great! When I look around this room, I can’t help but wonder, ‘Is Ozempic right for me?’” Semaglutide (Ozempic, Wegovy, and Rybelsus) is blowing up social media […]
Read MoreAuthor: Alexander A. Hannenberg, MD ASA Monitor September 2023, Vol. 87, 1–4. For decades, patient monitoring with oximetry and capnography has been an ASA standard of care. It is linked with our specialty’s benchmark improvement in outcomes. Yet even now, these tools remain largely unavailable across low- and middle-income countries. Lifebox was founded in 2011 to […]
Read More